James K. Glassman: An Unconscionable Mess as Maryland Attempts Drug Price Controls

Many states have decided to tackle the problem of rising health costs with regulations on pharmaceutical makers. But Maryland is going them one better. It wants to be the first state to empower its attorney general to take drug companies to court for “price gouging.” A judge can then fine the companies or force them to issue refunds.

Read Full Article